DLBCL: CAR-T as Curative Treatment/Bridge to Transplant – OncLive
OncLive |
DLBCL: CAR–T as Curative Treatment/Bridge to Transplant
OncLive Now, those relapses have sometimes been responsive to a second CAR T-cell infusion. At times, they've been limited in disease, even in patients who have bulky disease and we could get them to a CR, or near a CR, and then have taken these patients to … |
